BLAUVELT, A.; DRAELOS, Z. D.; GOODERHAM, M.; LAIN, E.; MOORE, A. Y.; PAPP, K. A.; ZIRWAS, M.; KRUPA, D.; BURNETT, P.; BERK, D. R.; CHU, D. H. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s226, 2023. DOI: 10.25251/skin.7.supp.226. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2193. Acesso em: 3 jul. 2024.